A groundbreaking trial has unveiled the remarkable potential of resistant starch, commonly found in foods like oats and slightly green bananas, in significantly reducing the risk of various cancers. Led by experts from the Universities of Newcastle and Leeds, the study, known as CAPP2, involved nearly 1,000 participants with Lynch syndrome from around the globe.
Lynch syndrome, affecting approximately one in 300 people in the UK, stems from a genetic fault that heightens the susceptibility to bowel, womb, ovarian, and other cancers. Individuals with Lynch syndrome face up to an 80% likelihood of developing bowel cancer in their lifetime, often at a younger age than the general population. Remarkably, the trial revealed that regular consumption of resistant starch, also known as fermentable fiber, over an average of two years, slashed the incidence of cancers in other parts of the body by more than half.
Continue reading… “Resistant Starch: A Promising Weapon Against Cancer”
